By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
vitalfork.comvitalfork.comvitalfork.com
Notification Show More
Font ResizerAa
  • Health & Wellness
    • Fitness
    • Workout
  • Celebs
    • Fashion
  • Food
    • Nutrition
    • Recipes
Reading: Weight loss drug Monjaro to launch in India in 2025; Know how it tackles obesity
Share
Font ResizerAa
vitalfork.comvitalfork.com
  • Health & Wellness
  • Celebs
  • Food
Search
  • Health & Wellness
    • Fitness
    • Workout
  • Celebs
    • Fashion
  • Food
    • Nutrition
    • Recipes
Have an existing account? Sign In
Follow US
vitalfork.com > Blog > Health & Wellness > Weight loss drug Monjaro to launch in India in 2025; Know how it tackles obesity
Weight loss drug Monjaro to launch in India in 2025; Know how it tackles obesity
Health & Wellness

Weight loss drug Monjaro to launch in India in 2025; Know how it tackles obesity

VitalFork
Last updated: December 26, 2024 4:30 am
VitalFork
Published December 26, 2024
Share
SHARE

Contents
Weight loss drug Monjaro to launch in India in 2025; Know how it tackles obesityHow does Monjaro work for diabetes and obesity,What is Monjaro?monjaro for weight lossShould you take Monjaro?
  • news

  • Health

Weight loss drug Monjaro to launch in India in 2025; Know how it tackles obesity

Global pharma giant Eli Lilly plans to launch its diabetes and obesity treatment, tirazepateide, in India by 2025, which will be marketed under the Monjaro and Zepbound brands. Proposed dosages range from 2.5 mg to 15 mg. Read on to know more about the medicine and how it helps in weight loss.
Weight loss drug Monjaro to launch in India in 2025; Know how it tackles obesity

The company has received marketing authorization from the relevant authorities for both type 2 diabetes and obesity indications

US pharma giant Eli Lilly plans to bring its obesity and diabetes drug tirazepate or Monzaro to India next year and has said it will price it “competitively and appropriately”. According to news reports, the company has received marketing authorization from the relevant authorities for both. Signs of type 2 diabetes and obesity.
“We aim to launch tirazeptide in India by 2025, after receiving other pending necessary regulatory approvals,” the spokesperson said. Business Standard.
“While we have not yet finalized the price of tirazepitide for India, Lilly is committed to ensuring that tirazepitide remains accessible to patients who need it. Our pricing strategy for tirazeptide in India will be competitive and appropriate, reflecting the drug’s efficacy and significant value in reducing the overall health and economic burden of type 2 diabetes and obesity.

How does Monjaro work for diabetes and obesity,

According to experts, obesity is a chronic disease – a metabolic dysfunction that affects your body down to the cellular level. Although it is important to exercise regularly and eat healthy, these steps alone do not fully help people with obesity achieve a healthy weight and increase their risk for other chronic conditions such as heart disease, diabetes and fatty liver disease. Do not minimize the risk.
And hence, diabetes medicines like Monjaro have immense effect in weight loss.

What is Monjaro?

monjaro is one Injectable medicine to treat type 2 diabetes And is available by prescription only. Experts say it works by targeting two hormones:
  • GLP-1, which is released from your digestive system, helps lower blood sugar and promotes feelings of fullness.
  • Glucose-dependent insulinotropic polypeptide – which stimulates the release of insulin.

Doctors say the drug changes your body’s response to food. It makes you feel full faster and changes your blood sugar levels, making it an extremely powerful tool to manage both diabetes and obesity.

monjaro for weight loss

Even though it is primarily a diabetes medicine, Monjaro helps significantly in reducing weight in obese people. Many studies and research say that this medicine is similar to another popular diabetes medicine, Ozempic, which has become popular worldwide for its weight loss effects. Ozempic is known by the generic name semaglutide.

Should you take Monjaro?

According to doctors, if you want to lose weight quickly for an event then you should avoid Monjaro. But if you’re living with diabetes or obesity, it’s worth a try. Your doctor will also recommend diet and exercise along with medication.
Also, since this is a long-term treatment, when you stop taking the medication, there are chances that your lost weight will come back again. Therefore, it is always best to discuss with a doctor who understands obesity how these medications work and what you should expect.
Get the latest news live on Times Now with breaking news and top headlines from around the world.

You Might Also Like

Optical Illusion Personality Test: What you notice first can reveal your hidden strengths and weaknesses

Why some Covid-19 cases become serious while others do not do

Why should you avoid drinking too much sugarcane juice in summer?

Can wearing glasses prevent dementia? Know how vision loss affects your brain health

Thinking too much can damage your brain, cause burnout – Scientists warn; find out how

Share This Article
Facebook Email Print
Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

©Vitalfork 2025 All Rights Reserved.
  • Contact us
  • About us
  • Privacy policy
Go to mobile version
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up